AMRX Amneal Pharmaceuticals Inc - Ordinary Shares - Class A
$17.65
$0.19
(1.05%)
Closed $17.87
$0.22
(1.23%)
After Hours
EarningsOct 29
Mkt Cap$5.77B
Vol2.73M
About AMRX
Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.
Fundamentals
44
Bearish Sentiment
How do you feel about AMRX?
